biontech vaccine - Search News

Pfizer, BioNTech and Germany

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

Fierce Pharma · 1h

Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech traded blows this week with rival Moderna as dueling decisions came down in | Moderna sued Pfizer and BioNTech over three patents protecting its COVID-19 work back in 2022.

Medical Xpress · 22h

Pfizer and BioNTech COVID vaccine broke patent: German court

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make their COVID-19 vaccine.

Medical Dialogues · 4h

Patent infringement: Pfizer convinces US Patent Office to cancel two Moderna coronavirus vaccine patents

Pfizer and BioNTech have convinced a U.S. Patent Office tribunal that two patents Moderna accused Pfizer-BioNtech of infringing were invalid. The companies have secured a victory in a round

DPA International on MSN · 23h

Moderna wins patent lawsuit against BioNTech/Pfizer in German court

A German court ruled on Wednesday that BioNTech and Pfizer violated a Covid-19 patent held by rival Moderna. US-based Moderna had asserted claims for information and damages for infringement of its patent rights in the development of the Covid-19 vaccine.

BioNTech, malaria vaccine and FDA

Clinical Trials Arena on MSN · 18h

FDA puts clinical hold on BioNTech’s malaria vaccine trial

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

U.S. FDA places clinical hold on BioNTech's malaria vaccine study

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an early-to-mid stage trial of its malaria vaccine.

FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount

The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC advisory committee meetings.

1don MSN

Health Rounds: Roche/BioNTech experimental vaccine shows early promise in pancreatic cancer

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

Moderna COVID Vaccine Technology Struck Down by PTAB

Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...

COVID 2024-25 vaccines 33% protective against emergency room or urgent care visits, data reveal

Late last week in Morbidity and Mortality Weekly Report, authors from the Centers for Disease Control and Prevention (CDC) ...

4don MSN

Is BioNTech SE (BNTX) The Best Immunology Stock To Buy Now?

We recently published a list of 10 Best Immunology Stocks To Buy Now. In this article, we are going to take a look at where ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results